Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001324210 | SCV001515154 | uncertain significance | Fanconi anemia | 2022-03-13 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 373 of the FANCB protein (p.Asp373Gly). This variant is present in population databases (no rsID available, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with FANCB-related conditions. ClinVar contains an entry for this variant (Variation ID: 1024072). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005005173 | SCV002779731 | uncertain significance | Fanconi anemia complementation group B | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003416208 | SCV004106717 | uncertain significance | FANCB-related disorder | 2023-03-24 | criteria provided, single submitter | clinical testing | The FANCB c.1118A>G variant is predicted to result in the amino acid substitution p.Asp373Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.029% of alleles in individuals of Latino descent in gnomAD, but has not been observed in the hemizygous state (http://gnomad.broadinstitute.org/variant/X-14876063-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |